Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 382

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 382
---
 to eliminate legacy subsidiaries of Denali; or |

| • |     | undertake any legally binding obligation to do any of the actions set forth the foregoing. |

223

Non-solicitationProvision Pursuant to the Merger Agreement, the parties have agreed that during the Interim Period neither Semnur on the one hand, or Denali and Merger Sub, on the other hand, will (and each of them will cause their respective officers, directors, affiliates, managers, consultants, employees, representatives and agents not to), directly or indirectly:

| • |     | solicit, initiate, engage or participate in, or knowingly encourage or facilitate, negotiations with any person or entity concerning, or make any offers or proposals related to, any Alternative Transaction (as defined below); |

| • |     | enter into, engage in or continue any discussions or negotiations with respect to an Alternative Transaction with, or provide any non-public information, data or access to employees to, any person or entity that has made, or to the respective party’s knowledge, is considering making, a proposal with respect to an Alternative Transaction; or |

| • |     | approve, recommend or enter into any Alternative Transaction or any contract related to any Alternative Transaction. |

The term “Alternative Transaction” means (other than the transactions contemplated by the Merger Agreement) (i) with respect to Semnur: (y) any transaction or series of related transactions under which any persons or entities, directly or indirectly, acquires or otherwise purchases Semnur, including through merger, consolidation, share exchange, business combination, amalgamation, recapitalization, or other similar transaction, (z) any sale, exchange, transfer or other disposition of 25% or more of the total assets of Semnur or any class or series of the share capital or capital stock or other equity interests of Semnur in a single transaction or series of related transactions that, if consummated, would result in any other person owning 25% or more of any class of equity or voting securities of Semnur; or (ii) with respect to Denali, any “Business Combination” as such term is defined in Denali’s organizational documents. Other Agreements of the Parties The Merger Agreement contains certain additional covenants of the parties, including covenants in connection with:

| • |     | providing the other party with reasonable access to its respective offices, properties and books and records; |

| • |     | notifying the other party of any occurrence